The Astral Systems £23M raise will scale medical isotopes for cancer scans, from a rare fusion firm already running reactors and earning revenue.

The Astral Systems £23M raise will scale medical isotopes for cancer scans, from a rare fusion firm already running reactors and earning revenue.

Bristol startup Astral Systems has raised £23M in Series A funding to scale fusion reactors that produce medical isotopes for cancer diagnosis and treatment.